• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Cordis US. Corp EXOSEAL; Device, Hemostasis, Vascular

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Cordis US. Corp EXOSEAL; Device, Hemostasis, Vascular Back to Search Results
Catalog Number EX700
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/14/2026
Type of Reportable Event Malfunction
Event or Problem Description
As reported, the indicator window of a 7f exoseal vascular closure device (vcd) did not change color at any point during withdrawal, even when the sheath tip was withdrawn outside the body, and closure failed.There was no reported patient injury.The device was used to close an 8f femoral artery sheath.The operating instructions were strictly followed, and the withdrawal angle was maintained during withdrawal of the sheath and closure device.During ex vivo testing, the guidewire loop required substantial pulling force, and the color-change response was insensitive.Hemostasis was achieved by compression.There were no visible signs of device or package damage prior to use.The device was stored and prepared according to the instructions for use (ifu).There was no difficulty connecting the vascular sheath introducer with the exoseal vascular closure device (vcd).The indicator wire cowling locked against the handle assembly, and an audible click was heard.Pulsatile flow was observed from the bleed-back indicator.The exoseal vcd and vascular sheath introducer were retracted together until bleed back significantly slowed or stopped.The indicator did not show a black-black state.The physician did not have their thumb on the plug deployment button during retraction.The indicator window did not show red during retraction.When the device was removed from the patient, the indicator wire loop was deployed/showing, with no anomalies noted.Deployment was attempted outside the patient's body; considerable force was required to pull the guidewire loop, and the indicator window was not sensitive to color change.An 11 cm femoral sheath was used.Femoral artery suitability was verified by angiography, including the vascular sheath introducer insertion angle of 30-45 degrees, and the vessel diameter was verified to be at least 5 mm.There was no visible calcium/plaque at the puncture site, access vessel tortuosity, stent near the puncture site, or stenosis greater than 50% at or near the puncture site.The target femoral site had not been closed with a closure device or manual compression less than 30 days before the procedure.There was no evidence of a pre-existing hematoma, arteriovenous fistula, or pseudoaneurysm at the access site before exoseal vcd use.The exoseal vcd was used in an interventional procedure with a retrograde approach.The patient's body mass index was not greater than 40.The physician had achieved certification on the use of the exoseal vcd.The device will be returned for evaluation.
 
Additional Manufacturer Narrative
Due to system limitations, section h6 required to input type of investigation, investigation findings, and investigation conclusions for an initial report.Pending additional information to complete investigation.This device is available for analysis, but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.Additional information is pending and will be submitted within 30 days upon receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXOSEAL
Common Device Name
Device, Hemostasis, Vascular
Manufacturer (Section D)
Cordis US. Corp
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
Cordis US Corp.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 32574
MX   32574
+011(786)3138372
MDR Report Key50687070
Report Number9616099-2026-01232
Device Sequence Number16039662
Product Code MGB
UDI-Device Identifier10705032058896
UDI-Public(01)10705032058896(17)271031(10)18524651
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P100013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 09/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberEX700
Device Lot Number18524651
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer08/28/2026
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/14/2026
Initial Report FDA Received Date09/09/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/05/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
unknown 8F sheath.
Patient Age54 YR
Patient SexFemale
Patient Weight132 LB
-
-